Elvira Tamarozzi

Mrs. Elvira Tamarozzi

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NMNatália Chermont dos Santos Moreira
Natália Chermont dos Santos Moreira
ETElvira Tamarozzi
Elvira Tamarozzi
JLJéssica Ellen Barbosa de Freitas Lima
Jéssica Ellen Barbosa de Freitas Lima
LPLarissa Oliveira Piassi
Larissa Oliveira Piassi
ICIvone Carvalho
Ivone Carvalho
ESElza Tiemi Sakamoto-Hojo 
Elza Tiemi Sakamoto-Hojo 
Alzheimer’s disease (AD) is a progressive and complex neurodegenerative disease. Acetylcholinesterase inhibitors (AChEIs) are a major class of drugs used in AD therapy. ROCK2, another promising target for AD, has been associated with the induction of neurogenesis via PTEN/AKT. This study aimed to characterize the therapeutic potential of a novel donepezil–tacrine hybrid compound (TA8Amino) to inhibit AChE and ROCK2 protein, leading to the induction of neurogenesis in SH-SY5Y cells. Experiments were carried out with undifferentiated and neuron-differentiated SH-SY5Y cells submitted to treatments with AChEIs (TA8Amino, donepezil, and tacrine) for 24 h or 7 days. TA8Amino was capable of inhibiting AChE at non-cytotoxic concentrations after 24 h. Following neuronal differentiation for 7 days, TA8Amino and donepezil increased the percentage of neurodifferentiated cells and the length of neurites, as confirmed by β-III-tubulin and MAP2 protein expression. TA8Amino was found to participate in the activation of PTEN/AKT signaling. In silico analysis showed that TA8Amino can stably bind to the active site of ROCK2, and in vitro experiments in SH-SY5Y cells demonstrate that TA8Amino significantly reduced the expression of ROCK2 protein, contrasting with donepezil and tacrine. Therefore, these results provide important information on the mechanism underlying the action of TA8Amino with regard to multi-target activities.

1 January 2014 in Genetics and Molecular Research
Verified
Journal Article
Closed access
ETElvira Tamarozzi
Elvira Tamarozzi
ETE. Torrieri
E. Torrieri
ESE.P. Semighiniand
E.P. Semighiniand
SGSilvana Giuliatti
Silvana Giuliatti
The goals were to analyze and characterize the secondary structure, regions of intrinsic disorder and physicochemical characteristics of three classes of mutations described in the enzyme N-acetylgalactosamine-6-sulfatase that cause mucopolysaccharidosis IVA: missense mutations, insertions and deletions. All mutations were compared to wild-type enzyme, and the results showed that with 25 of 129 missense mutations secondary structure was maintained and that 104 mutations showed minor changes, such as an increase or decrease in the size of the elements. The secondary structure of all insertions and deletions introduced important changes, such as increase in the number and size of elements. The results obtained from intrinsic disorder analysis revealed that missense mutations caused no alterations. However, the insertions and deletions led to major regions of intrinsic disorder. The physicochemical characteristics of the amino acids found in missense mutations revealed unchanged characteristics in 32 of the 129 mutations. However, the remainder had changes that could lead to a modification of tertiary structure. The results proved that it was feasible and necessary to obtain the three-dimensional structure of the enzyme with its mutants to better understand the change in function.